Here’s a brief look at therapies for neurological disorders that the FDA has approved within the past 6 months.
NeuroVoices: Scott Perry, MD, on the Intricacies and Value of Diagnosing Lennox-Gastaut Syndrome
Sleeping Around the Podcast × NeurologyLive: Candidate Biomarkers to Detect REM Sleep Behavior Disorder in Parkinson Disease
SAGE-718 Falls Short in Phase 2 PRECEDENT Study of Mild Cognitively Impaired Parkinson Disease
Episode 112: Exploring Dimethyl Fumarate to Treat Friedreich Ataxia
This Week on NeurologyLive® — April 22, 2024
Illuminating the Night: Understanding Parkinson Nighttime Symptoms